Literature DB >> 28839079

pH Conditions under Which Pyrazinamide Works in Humans.

Shashikant Srivastava1, Jotam G Pasipanodya1, Tawanda Gumbo2.   

Abstract

Entities:  

Keywords:  hollow-fiber system; mouse TB cavity; pH; pyrazinamide; tuberculosis

Mesh：

Substances：

Year:  2017        PMID： 28839079      PMCID： PMC5571337          DOI： 10.1128/AAC.00854-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.

Authors:  Tawanda Gumbo; Chandima S W Siyambalapitiyage Dona; Claudia Meek; Richard Leff
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

2.  Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

Authors:  W McDERMOTT; R TOMPSETT
Journal:  Am Rev Tuberc       Date:  1954-10

3.  Basic mechanisms of chemotherapy.

Authors:  D A Mitchison
Journal:  Chest       Date:  1979-12       Impact factor: 9.410

4.  Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.

Authors:  Russell R Kempker; M Tobias Heinrichs; Ketino Nikolaishvili; Irina Sabulua; Nino Bablishvili; Shota Gogishvili; Zaza Avaliani; Nestani Tukvadze; Brent Little; Adam Bernheim; Timothy D Read; Jeannette Guarner; Hartmut Derendorf; Charles A Peloquin; Henry M Blumberg; Sergo Vashakidze
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

5.  Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic.

Authors:  A J Crowle; R Dahl; E Ross; M H May
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

6.  Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.

Authors:  Jean-Philippe Lanoix; Fabrice Betoudji; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

7.  Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests.

Authors:  Soumya Swaminathan; Jotam G Pasipanodya; Geetha Ramachandran; A K Hemanth Kumar; Shashikant Srivastava; Devyani Deshpande; Eric Nuermberger; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2016-11-01       Impact factor: 9.079

8.  Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues.

Authors:  R M McCune; F M Feldmann; H P Lambert; W McDermott
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

9.  A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies.

Authors:  Shashikant Srivastava; Jotam G Pasipanodya; Geetha Ramachandran; Devyani Deshpande; Stephen Shuford; Howland E Crosswell; Kayle N Cirrincione; Carleton M Sherman; Soumya Swaminathan; Tawanda Gumbo
Journal:  EBioMedicine       Date:  2016-02-27       Impact factor: 8.143
  9 in total
  3 in total

1.  Reply to Srivastava et al., "pH Conditions under Which Pyrazinamide Works in Humans".

Authors:  Russell R Kempker; Charles A Peloquin; Henry M Blumberg; Sergo Vashakidze
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.

Authors:  Devyani Deshpande; Shashikant Srivastava; Paula Bendet; Katherine R Martin; Kayle N Cirrincione; Pooi S Lee; Jotam G Pasipanodya; Keertan Dheda; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

3.  Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis.

Authors:  Suresh Mallikaarjun; Moti L Chapagain; Tomohiro Sasaki; Norimitsu Hariguchi; Devyani Deshpande; Shashikant Srivastava; Alexander Berg; Kuniko Hirota; Yusuke Inoue; Makoto Matsumoto; Jeffrey Hafkin; Lawrence Geiter; Xiaofeng Wang; Tawanda Gumbo; Yongge Liu
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.